LONDON, Jan. 26 /PRNewswire/ -- Double Helix Consulting US (DHC US), headed by Andrew M. Baker, President, joins a multidisciplinary team of highly experienced strategic pricing, reimbursement and market access consultants with extensive experience across the healthcare industry as well as strong commercial, governmental and academic links, who provide customer-centric market access strategies to clients in the pharmaceutical, biotechnology and medical device industries. DHC US provides services spanning the product lifecycle, including the following:
Speaking about the new business, Drew commented "Double Helix Consulting US offers a premier set of services to assist our clients in optimizing product commercialization by enhancing market access through a truly global team of professionals with deep experience from both the client- and consulting sides. As an example, our growing emerging markets practice provides clients with the intelligence to implement successful strategies in the world's largest and most rapidly developing economies."
Based in the greater New York area, Double Helix Consulting US j
|SOURCE Double Helix Consulting US|
Copyright©2009 PR Newswire.
All rights reserved